TreeWAS – Variant ID: rs12541635

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.4 Disorders of magnesium metabolism	0.013	0.987	0.000
Z29.0 Isolation	0.000	0.987	0.012
C15.5 Lower third of oesophagus	0.000	0.989	0.011
O14.9 Preeclampsia, unspecified	0.010	0.990	0.000
F20.9 Schizophrenia, unspecified	0.009	0.991	0.000
M79.79 Fibromyalgia (Site unspecified)	0.009	0.991	0.000
L52 Erythema nodosum	0.009	0.991	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.008	0.992	0.000
Z86.1 Personal history of infectious and parasitic diseases	0.000	0.992	0.008
L50 Urticaria	0.008	0.992	0.000
L50-L54 Urticaria and erythema	0.008	0.992	0.000
D09.0 Bladder	0.008	0.992	0.000
L50.9 Urticaria, unspecified	0.008	0.992	0.000
L50.8 Other urticaria	0.008	0.992	0.000
L53.8 Other specified erythematous conditions	0.008	0.992	0.000
L53 Other erythematous conditions	0.007	0.993	0.000
C15 Malignant neoplasm of oesophagus	0.000	0.993	0.007
M79.0 Rheumatism, unspecified	0.006	0.994	0.000
F20 Schizophrenia	0.006	0.994	0.000
D09 Carcinoma in situ of other and unspecified sites	0.006	0.994	0.000
C15.9 Oesophagus, unspecified	0.000	0.994	0.006
M79.7 Fibromyalgia	0.006	0.994	0.000
T39.0 Salicylates	0.006	0.994	0.000
L53.0 Toxic erythema	0.006	0.994	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.006	0.994	0.000
L50.6 Contact urticaria	0.006	0.994	0.000
L50.5 Cholinergic urticaria	0.006	0.994	0.000
L50.4 Vibratory urticaria	0.006	0.994	0.000
L50.3 Dermatographic urticaria	0.006	0.994	0.000
L50.2 Urticaria due to cold and heat	0.006	0.994	0.000
L54 Erythema in diseases classified elsewhere	0.006	0.994	0.000
C15.4 Middle third of oesophagus	0.000	0.994	0.006
L50.1 Idiopathic urticaria	0.006	0.994	0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.006	0.994	0.000
D09.1 Other and unspecified urinary organs	0.005	0.994	0.000
F20.8 Other schizophrenia	0.005	0.994	0.000
D09.9 Carcinoma in situ, unspecified	0.005	0.994	0.000
C48.2 Peritoneum, unspecified	0.005	0.995	0.000
L53.3 Other chronic figurate erythema	0.005	0.995	0.000
L53.2 Erythema marginatum	0.005	0.995	0.000
L53.1 Erythema annulare centrifugum	0.005	0.995	0.000
D30.3 Bladder	0.005	0.995	0.000
L51 Erythema multiforme	0.005	0.995	0.000
D09.7 Carcinoma in situ of other specified sites	0.005	0.995	0.000
C15.3 Upper third of oesophagus	0.000	0.995	0.005
C15.8 Overlapping lesion of oesophagus	0.000	0.995	0.005
C15.2 Abdominal part of oesophagus	0.000	0.995	0.005
C15.1 Thoracic part of oesophagus	0.000	0.995	0.005
M79.09 Rheumatism, unspecified (Site unspecified)	0.005	0.995	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.005	0.995	0.000
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.005	0.995	0.000
M79.04 Rheumatism, unspecified (Hand)	0.005	0.995	0.000
M79.03 Rheumatism, unspecified (Forearm)	0.005	0.995	0.000
M79.02 Rheumatism, unspecified (Upper arm)	0.005	0.995	0.000
D09.3 Thyroid and other endocrine glands	0.005	0.995	0.000
D09.2 Eye	0.005	0.995	0.000
F20.6 Simple schizophrenia	0.005	0.995	0.000
F20.4 Postschizophrenic depression	0.005	0.995	0.000
F20.3 Undifferentiated schizophrenia	0.005	0.995	0.000
F20.1 Hebephrenic schizophrenia	0.005	0.995	0.000
G12.2 Motor neuron disease	0.005	0.995	0.000
M79.78 Fibromyalgia (Other)	0.004	0.995	0.000
M79.77 Fibromyalgia (Ankle and foot)	0.004	0.995	0.000
M79.76 Fibromyalgia (Lower leg)	0.004	0.995	0.000
M79.75 Fibromyalgia (Pelvic region and thigh)	0.004	0.995	0.000
M79.74 Fibromyalgia (Hand)	0.004	0.995	0.000
M79.73 Fibromyalgia (Forearm)	0.004	0.995	0.000
M79.72 Fibromyalgia (Upper arm)	0.004	0.995	0.000
M79.71 Fibromyalgia (Shoulder region)	0.004	0.995	0.000
F20.0 Paranoid schizophrenia	0.005	0.995	0.000
M79.06 Rheumatism, unspecified (Lower leg)	0.004	0.995	0.000
M79.70 Fibromyalgia (Multiple sites)	0.004	0.995	0.000
S72.10 Pertrochanteric fracture (closed)	0.000	0.996	0.004
L54.8 Erythema in other diseases classified elsewhere	0.004	0.996	0.000
L54.0 Erythema marginatum in acute rheumatic fever	0.004	0.996	0.000
C15.0 Cervical part of oesophagus	0.000	0.996	0.004
D30.0 Kidney	0.004	0.996	0.000
O14.2 HELLP syndrome	0.004	0.996	0.000
F20.2 Catatonic schizophrenia	0.004	0.996	0.000
M79.08 Rheumatism, unspecified (Other)	0.004	0.996	0.000
F22.0 Delusional disorder	0.004	0.996	0.000
F22 Persistent delusional disorders	0.004	0.996	0.000
L51.1 Bullous erythema multiforme	0.004	0.996	0.000
D30 Benign neoplasm of urinary organs	0.004	0.996	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.004	0.996	0.000
M79.96 Soft tissue disorder, unspecified (Lower leg)	0.004	0.996	0.000
E83.3 Disorders of phosphorus metabolism	0.004	0.996	0.000
L51.8 Other erythema multiforme	0.004	0.996	0.000
L51.2 Toxic epidermal necrolysis [Lyell]	0.004	0.996	0.000
L51.0 Nonbullous erythema multiforme	0.004	0.996	0.000
O14.1 Severe preeclampsia	0.004	0.996	0.000
O14.0 Moderate preeclampsia	0.004	0.996	0.000
E83 Disorders of mineral metabolism	0.004	0.996	0.000
M79.9 Soft tissue disorder, unspecified	0.004	0.996	0.000
F20.5 Residual schizophrenia	0.004	0.996	0.000
L50.0 Allergic urticaria	0.004	0.996	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.004	0.996	0.000
M79.99 Soft tissue disorder, unspecified (Site unspecified)	0.004	0.996	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.004	0.996	0.000
M79 Other soft tissue disorders, not elsewhere classified	0.004	0.996	0.000
F22.9 Persistent delusional disorder, unspecified	0.003	0.996	0.000
F21 Schizotypal disorder	0.003	0.996	0.000
C48.1 Specified parts of peritoneum	0.003	0.996	0.000
M79.2 Neuralgia and neuritis, unspecified	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
M79.25 Neuralgia and neuritis, unspecified (Pelvic region and thigh)	0.003	0.996	0.000
M79.28 Neuralgia and neuritis, unspecified (Other)	0.003	0.996	0.000
O71.4 Obstetric high vaginal laceration alone	0.000	0.997	0.003
F23 Acute and transient psychotic disorders	0.003	0.997	0.000
D30.4 Urethra	0.003	0.997	0.000
L51.9 Erythema multiforme, unspecified	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
F22.8 Other persistent delusional disorders	0.003	0.997	0.000
L53.9 Erythematous condition, unspecified	0.003	0.997	0.000
M79.97 Soft tissue disorder, unspecified (Ankle and foot)	0.003	0.997	0.000
L60.8 Other nail disorders	0.000	0.997	0.003
C48.0 Retroperitoneum	0.003	0.997	0.000
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.003	0.997	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.997	0.003
D30.9 Urinary organ, unspecified	0.003	0.997	0.000
D30.7 Other urinary organs	0.003	0.997	0.000
D30.2 Ureter	0.003	0.997	0.000
D30.1 Renal pelvis	0.003	0.997	0.000
F28 Other nonorganic psychotic disorders	0.003	0.997	0.000
F24 Induced delusional disorder	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.003	0.997	0.000
F25 Schizoaffective disorders	0.003	0.997	0.000
E83.8 Other disorders of mineral metabolism	0.003	0.997	0.000
E83.2 Disorders of zinc metabolism	0.003	0.997	0.000
E83.0 Disorders of copper metabolism	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
M79.93 Soft tissue disorder, unspecified (Forearm)	0.003	0.997	0.000
M79.92 Soft tissue disorder, unspecified (Upper arm)	0.003	0.997	0.000
M79.91 Soft tissue disorder, unspecified (Shoulder region)	0.003	0.997	0.000
M79.90 Soft tissue disorder, unspecified (Multiple sites)	0.003	0.997	0.000
N81.8 Other female genital prolapse	0.000	0.997	0.003
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.003	0.997	0.000
M79.94 Soft tissue disorder, unspecified (Hand)	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
I97.1 Other functional disturbances following cardiac surgery	0.000	0.997	0.003
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
M79.98 Soft tissue disorder, unspecified (Other)	0.003	0.997	0.000
C69.3 Choroid	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
M79.3 Panniculitis, unspecified	0.003	0.997	0.000
Z04.8 Examination and observation for other specified reasons	0.000	0.997	0.003
F25.1 Schizoaffective disorder, depressive type	0.003	0.997	0.000
M79.95 Soft tissue disorder, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
M79.24 Neuralgia and neuritis, unspecified (Hand)	0.003	0.997	0.000
M79.23 Neuralgia and neuritis, unspecified (Forearm)	0.003	0.997	0.000
M79.22 Neuralgia and neuritis, unspecified (Upper arm)	0.003	0.997	0.000
M79.21 Neuralgia and neuritis, unspecified (Shoulder region)	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
G12 Spinal muscular atrophy and related syndromes	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
M79.26 Neuralgia and neuritis, unspecified (Lower leg)	0.003	0.997	0.000
F23.8 Other acute and transient psychotic disorders	0.003	0.997	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
N05.8 Other	0.003	0.997	0.000
O10.0 Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium	0.003	0.997	0.000
O15 Eclampsia	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.002	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
M79.27 Neuralgia and neuritis, unspecified (Ankle and foot)	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
R94.4 Abnormal results of kidney function studies	0.003	0.997	0.000
O11 Pre-existing hypertensive disorder with superimposed proteinuria	0.003	0.997	0.000
F25.2 Schizoaffective disorder, mixed type	0.002	0.997	0.000
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.000	0.997	0.003
M79.20 Neuralgia and neuritis, unspecified (Multiple sites)	0.002	0.997	0.000
G45.0 Vertebro-basilar artery syndrome	0.000	0.997	0.003
G80.9 Infantile cerebral palsy, unspecified	0.000	0.997	0.003
M79.4 Hypertrophy of (infrapatellar) fat pad	0.002	0.997	0.000
C69 Malignant neoplasm of eye and adnexa	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
F25.8 Other schizoaffective disorders	0.002	0.997	0.000
O10.9 Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.002	0.997	0.000
O71.9 Obstetric trauma, unspecified	0.000	0.997	0.003
G45.1 Carotid artery syndrome (hemispheric)	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.997	0.000
T46.7 Peripheral vasodilators	0.002	0.997	0.000
T90.4 Sequelae of injury of eye and orbit	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
C69.0 Conjunctiva	0.002	0.997	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.002	0.997	0.000
S72.1 Pertrochanteric fracture	0.000	0.997	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.003	0.997	0.000
T36.0 Penicillins	0.002	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
O12.2 Gestational oedema with proteinuria	0.002	0.998	0.000
O12.0 Gestational oedema	0.002	0.998	0.000
W22.9 Unspecified place	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
F25.0 Schizoaffective disorder, manic type	0.002	0.998	0.000
O10.4 Pre-existing secondary hypertension complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O10.3 Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O10.2 Pre-existing hypertensive renal disease complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O10.1 Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
O12.1 Gestational proteinuria	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
Z47.8 Other specified orthopaedic follow-up care	0.002	0.998	0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
N05.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
C71.3 Parietal lobe	0.002	0.998	0.000
E83.1 Disorders of iron metabolism	0.002	0.998	0.000
O15.2 Eclampsia in the puerperium	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
M79.39 Panniculitis, unspecified (Site unspecified)	0.002	0.998	0.000
M79.38 Panniculitis, unspecified (Other)	0.002	0.998	0.000
M79.37 Panniculitis, unspecified (Ankle and foot)	0.002	0.998	0.000
M79.36 Panniculitis, unspecified (Lower leg)	0.002	0.998	0.000
M79.35 Panniculitis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M79.34 Panniculitis, unspecified (Hand)	0.002	0.998	0.000
M79.33 Panniculitis, unspecified (Forearm)	0.002	0.998	0.000
M79.32 Panniculitis, unspecified (Upper arm)	0.002	0.998	0.000
M79.31 Panniculitis, unspecified (Shoulder region)	0.002	0.998	0.000
M79.30 Panniculitis, unspecified (Multiple sites)	0.002	0.998	0.000
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified	0.000	0.998	0.002
G44.2 Tension-type headache	0.000	0.998	0.002
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.000	0.998	0.002
T45.5 Anticoagulants	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
C69.2 Retina	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
G12.9 Spinal muscular atrophy, unspecified	0.002	0.998	0.000
G12.8 Other spinal muscular atrophies and related syndromes	0.002	0.998	0.000
G12.1 Other inherited spinal muscular atrophy	0.002	0.998	0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.002	0.998	0.000
G45.9 Transient cerebral ischaemic attack, unspecified	0.000	0.998	0.002
L81.9 Disorder of pigmentation, unspecified	0.002	0.998	0.000
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.002	0.998	0.000
M20.0 Deformity of finger(s)	0.000	0.998	0.002
T36.4 Tetracyclines	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
C69.6 Orbit	0.002	0.998	0.000
G45.3 Amaurosis fugax	0.000	0.998	0.002
H59.0 Vitreous syndrome following cataract surgery	0.000	0.998	0.002
O15.9 Eclampsia, unspecified as to time period	0.002	0.998	0.000
O15.1 Eclampsia in labour	0.002	0.998	0.000
O15.0 Eclampsia in pregnancy	0.002	0.998	0.000
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns	0.000	0.998	0.002
S82.00 Fracture of patella (closed)	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.998	0.002
N05 Unspecified nephritic syndrome	0.002	0.998	0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.000	0.998	0.002
O71 Other obstetric trauma	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
M79.49 Hypertrophy of (infrapatellar) fat pad-Site unspec	0.002	0.998	0.000
M79.48 Hypertrophy of (infrapatellar) fat pad (Other)	0.002	0.998	0.000
M79.47 Hypertrophy of (infrapatellar) fat pad (Ankle and foot)	0.002	0.998	0.000
M79.45 Hypertrophy of (infrapatellar) fat pad (Pelvic region and thigh)	0.002	0.998	0.000
M79.44 Hypertrophy of (infrapatellar) fat pad (Hand)	0.002	0.998	0.000
M79.43 Hypertrophy of (infrapatellar) fat pad (Forearm)	0.002	0.998	0.000
M79.42 Hypertrophy of (infrapatellar) fat pad (Upper arm)	0.002	0.998	0.000
M79.41 Hypertrophy of (infrapatellar) fat pad (Shoulder region)	0.002	0.998	0.000
M79.40 Hypertrophy of (infrapatellar) fat pad (Multiple sites)	0.002	0.998	0.000
C69.8 Overlapping lesion of eye and adnexa	0.002	0.998	0.000
C69.5 Lachrymal gland and duct	0.002	0.998	0.000
C69.4 Ciliary body	0.002	0.998	0.000
C69.1 Cornea	0.002	0.998	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.002	0.998	0.000
H47.3 Other disorders of optic disk	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
Z96.2 Presence of otological and audiological implants	0.000	0.998	0.002
C69.9 Eye, unspecified	0.002	0.998	0.000
Q23.1 Congenital insufficiency of aortic valve	0.002	0.998	0.000
X10.0 Home	0.002	0.998	0.000
S72.11 Pertrochanteric fracture (open)	0.000	0.998	0.002
O82.0 Delivery by elective Caesarean section	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
F29 Unspecified nonorganic psychosis	0.002	0.998	0.000
I97 Postprocedural disorders of circulatory system, not elsewhere classified	0.000	0.998	0.002
D05.0 Lobular carcinoma in situ	0.002	0.998	0.000
E23.2 Diabetes insipidus	0.000	0.998	0.002
H47.0 Disorders of optic nerve, not elsewhere classified	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
C09.9 Tonsil, unspecified	0.000	0.998	0.002
F25.9 Schizoaffective disorder, unspecified	0.002	0.998	0.000
G44.0 Cluster headache syndrome	0.000	0.998	0.002
T18.1 Foreign body in oesophagus	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
G55.2 Nerve root and plexus compressions in spondylosis	0.000	0.998	0.002
N48.6 Balanitis xerotica obliterans	0.002	0.998	0.000
N60.0 Solitary cyst of breast	0.002	0.998	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.998	0.002
I97.2 Postmastectomy lymphoedema syndrome	0.000	0.998	0.002
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.002	0.998	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
N05.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
O71.7 Obstetric haematoma of pelvis	0.000	0.998	0.002
C25.0 Head of pancreas	0.000	0.998	0.002
G80.8 Other infantile cerebral palsy	0.000	0.998	0.002
G44 Other headache syndromes	0.000	0.998	0.002
G80 Infantile cerebral palsy	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.002	0.998	0.000
K75.9 Inflammatory liver disease, unspecified	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
G45.2 Multiple and bilateral precerebral artery syndromes	0.000	0.998	0.002
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.998	0.002
Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons	0.000	0.998	0.002
G80.1 Spastic diplegia	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.002	0.998	0.000
N05.6 Dense deposit disease	0.002	0.998	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N05.0 Minor glomerular abnormality	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
M81.09 Postmenopausal osteoporosis (Site unspecified)	0.002	0.998	0.000
D06.9 Cervix, unspecified	0.002	0.998	0.000
O71.8 Other specified obstetric trauma	0.000	0.998	0.002
O71.2 Postpartum inversion of uterus	0.000	0.998	0.002
O71.1 Rupture of uterus during labour	0.000	0.998	0.002
O71.0 Rupture of uterus before onset of labour	0.000	0.998	0.002
D00-D09 In situ neoplasms	0.002	0.998	0.000
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.002	0.998	0.000
Z29 Need for other prophylactic measures	0.000	0.998	0.002
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.002	0.998	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.000	0.998	0.002
M79.8 Other specified soft tissue disorders	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
D06 Carcinoma in situ of cervix uteri	0.002	0.998	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.000	0.998	0.002
O71.5 Other obstetric injury to pelvic organs	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
D07.4 Penis	0.002	0.998	0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.002	0.998	0.000
M82.10 Osteoporosis in endocrine disorders (Multiple sites)	0.002	0.998	0.000
N36.2 Urethral caruncle	0.002	0.998	0.000
D07.5 Prostate	0.002	0.998	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.001	0.998	0.000
O81.4 Vacuum extractor delivery	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.000	0.998	0.002
M79.81 Other specified soft tissue disorders (Shoulder region)	0.002	0.998	0.000
M96.8 Other postprocedural musculoskeletal disorders	0.000	0.998	0.002
O71.6 Obstetric damage to pelvic joints and ligaments	0.000	0.998	0.002
O16 Unspecified maternal hypertension	0.002	0.998	0.000
D02.2 Bronchus and lung	0.002	0.998	0.000
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.000	0.998	0.002
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
H55 Nystagmus and other irregular eye movements	0.000	0.998	0.002
C71.1 Frontal lobe	0.002	0.998	0.000
G80.2 Infantile hemiplegia	0.000	0.998	0.002
M82.1 Osteoporosis in endocrine disorders	0.002	0.998	0.000
N05.9 Unspecified	0.002	0.998	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.001	0.998	0.000
M79.84 Other specified soft tissue disorders (Hand)	0.002	0.998	0.000
D07.3 Other and unspecified female genital organs	0.002	0.998	0.000
G80.4 Ataxic cerebral palsy	0.000	0.998	0.002
G80.3 Dyskinetic cerebral palsy	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
T44.0 Anticholinesterase agents	0.001	0.998	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.002	0.998	0.000
J04.1 Acute tracheitis	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
O82 Single delivery by Caesarean section	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.001	0.998	0.000
D07.6 Other and unspecified male genital organs	0.001	0.998	0.000
D07.0 Endometrium	0.001	0.998	0.000
I97.9 Postprocedural disorder of circulatory system, unspecified	0.000	0.998	0.001
O82.9 Delivery by Caesarean section, unspecified	0.002	0.998	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.002	0.998	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.002	0.998	0.000
D06.1 Exocervix	0.001	0.998	0.000
G80.0 Spastic cerebral palsy	0.000	0.998	0.001
O71.3 Obstetric laceration of cervix	0.000	0.998	0.001
M47.82 Other spondylosis (Cervical region)	0.000	0.998	0.002
G44.3 Chronic posttraumatic headache	0.000	0.998	0.001
H47.2 Optic atrophy	0.002	0.998	0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.000	0.998	0.002
D01.0 Colon	0.001	0.998	0.000
D07.1 Vulva	0.002	0.998	0.000
H47.7 Disorder of visual pathways, unspecified	0.001	0.998	0.000
H47.6 Disorders of visual cortex	0.001	0.998	0.000
H47.4 Disorders of optic chiasm	0.001	0.998	0.000
I97.0 Postcardiotomy syndrome	0.000	0.998	0.001
Z29.9 Prophylactic measure, unspecified	0.000	0.998	0.001
R54 Senility	0.000	0.998	0.002
D06.7 Other parts of cervix	0.001	0.998	0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.000	0.998	0.002
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.001	0.998	0.000
C25.9 Pancreas, unspecified	0.000	0.998	0.002
D07.2 Vagina	0.001	0.998	0.000
H47.5 Disorders of other visual pathways	0.001	0.998	0.000
R90.0 Intracranial space-occupying lesion	0.000	0.998	0.002
X59.3 Sports and athletics area	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.998	0.002
G44.1 Vascular headache, not elsewhere classified	0.000	0.998	0.001
M80.0 Postmenopausal osteoporosis with pathological fracture	0.001	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.001	0.998	0.000
Y76.2 Prosthetic and other implants, materials and accessory devices	0.001	0.998	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
D00.1 Oesophagus	0.001	0.998	0.000
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.000	0.998	0.001
M79.5 Residual foreign body in soft tissue	0.001	0.998	0.001
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.001	0.998	0.000
H55-H59 Other disorders of eye and adnexa	0.000	0.998	0.002
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac	0.000	0.999	0.001
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar	0.000	0.999	0.001
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol	0.000	0.999	0.001
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic	0.000	0.999	0.001
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot	0.000	0.999	0.001
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical	0.000	0.999	0.001
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-	0.000	0.999	0.001
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit	0.000	0.999	0.001
M79.88 Other specified soft tissue disorders (Other)	0.001	0.999	0.000
D05.7 Other carcinoma in situ of breast	0.001	0.999	0.000
M82.19 Osteoporosis in endocrine disorders (Site unspecified)	0.001	0.999	0.000
M82.18 Osteoporosis in endocrine disorders (Other)	0.001	0.999	0.000
M82.17 Osteoporosis in endocrine disorders (Ankle and foot)	0.001	0.999	0.000
M82.16 Osteoporosis in endocrine disorders (Lower leg)	0.001	0.999	0.000
M82.15 Osteoporosis in endocrine disorders (Pelvic region and thigh)	0.001	0.999	0.000
M82.14 Osteoporosis in endocrine disorders (Hand)	0.001	0.999	0.000
M82.13 Osteoporosis in endocrine disorders (Forearm)	0.001	0.999	0.000
M82.12 Osteoporosis in endocrine disorders (Upper arm)	0.001	0.999	0.000
N00.9 Unspecified	0.001	0.999	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.999	0.000
D02.4 Respiratory system, unspecified	0.001	0.999	0.000
D02.3 Other parts of respiratory system	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations